Skip to content

Validation of myStrength's Macropersonalization Engine

Validation of myStrength's Macropersonalization Engine

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05417178
Acronym
PAG-Macro
Enrollment
200
Registered
2022-06-14
Start date
2022-05-01
Completion date
2023-03-31
Last updated
2022-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Anxiety, Trauma

Keywords

Sleep, Digital Therapy

Brief summary

This is a study to validate myStrength's macropersonalization algorithm. Specifically, the study seeks to answer: Does myStrength's macropersonalization algorithm match what a clinician would offer as a diagnosis following an expert assessment? Participants will be treatment-seeking adults, ages 18 to 65, recruited from an evidence-based group psychotherapy practice. Participants will be asked to complete myStrength onboarding and a clinician-conducted initial assessment. Inter-rater reliability will be assessed to determine the consistency between myStrength and clinician in primary focus area of digital program.

Detailed description

Rationale and Background: Macropersonalization refers to the rules applied to a member's onboarding data that dictate their primary clinical focus and available interventions that will be recommended. Macropersonalization is a new myStrength feature that is meant to enable myStrength's ability to deliver evidence-based stepped care. Research Questions: To examine the inter-rater reliability between myStrength's macropersonalization engine and expert clinical recommendations for members' primary clinical focus. Study Design: This is a one-arm, prospective study. Population: Study participants will be adults, ages 18 to 65, seeking therapy at an evidence-based psychotherapy group practice. Data Sources: Anticipated data sources include members myStrength onboarding data, macropersonalization outputs, and clinician-administered clinical assessments. Data Analysis: A Cohen's kappa will be generated for agreement between myStrength macro-personalization primary focus area and clinician diagnosis to fulfill the primary objective. Conditional kappas based on stratification, as well as a logistic regression, will be used to determine whether demographics or treatment history are associated with concordance, and qualitative analyes will be used to describe sub-clinical or secondary focus areas associated with clinician diagnoses.

Interventions

OTHERmyStrength Macropersonalization Enginge

An onboarding process that utilizes the PHQ-9, GAD-7, and WHO-5 that leads to a user of the digital program's clinical focus and primary, secondary, and tertiary intervention recommendations.

Sponsors

Teladoc Health
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18 to 85, inclusive * Able to read, write, and speak in English * Has access to the Internet to complete study procedures * Currently engaged in therapy or has schedule an initial appointment with the Pacific Anxiety Group

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Inter-rater reliability on primary focus areaUpon completion of initial assessments by subject and clinician within 30 days of signing informed consent.Inter-rater reliability between myStrength macropersonalization engine and expert clinical recommendation for an individual's primary focus

Countries

United States

Contacts

Primary ContactJessica Yu, PhD
jessica.yu@teladochealth.com650-804-8434
Backup ContactSravanthi Dama, MD, MPH
sravanthia.dama@teladochealth.com347-645-0140

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026